Skip Trinity Banner Navigation

Skip to main content »

Trinity College Dublin

Personal Information
College Photo Name Radomski, Marek
Main Department Pharmacy
College Title Chair of Pharmacology (1979)
E-mail marek.radomski@tcd.ie
College Tel +353 1 896 2819
Web http://scholar.google.com/citations?user=wGSCyU4AAAAJ&hl=en
 
Biography
Born in Bochnia, Poland. High School: Liceum Jana Matejki in Wieliczka, Poland. A medical graduate of College of Medicine Jagiellonski University in Krakow, Poland. PhD in pharmacology from College of Medicine Jagiellonski University. A highly-cited pharmacologist (listed in www.isihighlycited.com, 17,968 citations to date by Google Scholar) who worked both in academia and pharmaceutical industry in Poland (Jagiellonian University in Krakow, Polish Academy of Sciences in Warsaw and Silesian Centre for Heart Diseases), UK (Wellcome Research Laboratories in Beckenham), Spain (Lacer SA in Barcelona), Canada (University of Alberta in Edmonton) and USA (University of Texas in Houston. He joined School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin in 2006 as Professor and Chair of Pharmacology. He served as Director of Research and Head of the School of Pharmacy. He contributed to undergraduate teaching of medical,dentistry, nursing and pharmacy students in Europe, Canada and USA. He mentored many MSc, PhD students, as well as post-doctoral researchers.
 
Representations
Details Date
Panels: Planing and Priorities Committee, Perinatal Research Centre, University of Alberta Curriculum Innovation Committee, Medical Faculty University of ALberta Health Sciences Animal Welfare Committee, Graduate Study Executive Committee, Department of Pharmacology University of Alberta Clinical Research Working Group, University of Alberta Medical Resident Research Evaluation Panel, University of Alberta Medical Student Admission Committee, National Institute of Health (USA), Special Emphasis Panel of the Womenm's Health RFA Canadian Institute of Health Research: University-Industry Committee(scientific officer) Bayer-CBS-Hema-Quebec-Canadian Institutes of Health Research Partnership Fund (scientific officer), Canadian Institute of Health Research: New Investigators Award Committee Canadian Institutes of Health Research: Proof of Principle Studies, Canadian Institutes of Health Research CIHR/Rx&D Collaborative Research Chair Program (scientific officer).
Phytopharm (UK)
Enterprise Ireland
Netherlands Heart Foundation
Biotechnology and Biological Sciences Research Council (UK)
More Representations>>>
 
Membership of Professional Institutions, Associations, Societies
Details Date From Date To
World Innovation Foundation 2005
 
Awards and Honours
Award Date
Alberta Heritage Foundation for Medical Research Scholar 1994-2000
Canadian Insititutes of Health Research Scientist 1999-2002
University of Alberta McCalla Research Professorship 1999-2000
Canadian Pharmacological Society Alta-Pharm International Senior Scientist Award 2001
State Professorship presented by President of the Republic of Poland 2002
More Awards and Honours>>>
 
Languages
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
French Medium Medium Medium
Polish Fluent Fluent Fluent
Russian Medium Medium Medium
 
Description of Research Interests
1. Nanopharmacology, nanoparticles and nanotoxicology. 2. Mechanisms regulating haemostatic and non-haemostatic functions of platelets. 3. Biology and pharmacology of nitric oxide and matrix metalloproteinases. 4. Extracorporeal circulation.
 
Research Interests
Angiogenesis Asthma, Cystic Fibrosis, obstructive airways, interstitial lung diseases, pulmonary fibrosis Breast cancer Cardiovascular and molecular pharmacology
Coronary artery ischaemia Cytokines, Nitric Oxide Drug discovery, profiling, targeting Haemotology
Inflammation NANOBIOTECHNOLOGY Nanomedicine Pharmacology
Pharmacy Thrombosis and haemostasis Vascular Biology, Thrombosis
 
Research Projects
Project title Nanopharmacology in platelet research: focus on nitric oxide and matrix metalloproteinases
Summary
Funding Agency Science Foundation Ireland
Programme SFI Investigator Programme
Type of Project
Date from 2006
Date to 2100
Person Months


Project title BioNanoInteract
Summary
Funding Agency SFI
Programme Strategic Research Cluster
Type of Project
Date from 2007
Date to 2010
Person Months


Project title Preclinical Development od Aspirin-based drugs
Summary
Funding Agency Enterprise Ireland
Programme Technology Development Phase
Type of Project
Date from 2007
Date to 2009
Person Months


 
Publications and Other Research Outputs
Peer Reviewed
Jun Wang, Carlos Medina, Marek W. Radomski, John F. Gilmer, N-subsituted homopiperazine barbiturates as gelatinase inhibitors, Bioorganic & Medicinal Chemistry, 19, (16), 2011, p4985-4999
TARA - Full Text
Santos-Martinez, MJ, Medina, C, Prina-Mello, A, Conroy, J, Samuels, SP, Volkov, Y, Radomski, MW, A nanoscale resolution assay of flow-induced platelet microaggregation, Kardiochirurgia i Torakochirurgia Polska, 7, (4), 2010, p365-375
Gaffney, A.M., Wildhirt, S.M., Griffin, M.J., Annich, G.M., Radomski, M.W., Extacorporeal life support, British Medical Journal, 341, 2010, c5317
Notes: [PubMed ID: 21045023]
DOI
Jones, M., Inkielewicz, I., Medina, C., Santos-Martinzez, M.J., Radomski, M.W., Radomski, A., Lally, M.N., Moriarty, L.M., Gaynor, J., Carolan, C.G., Coyne, D., O'Byrne, P., Clancy, J.M., Gilmer, J.F. , Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups. , Journal of Medicinal Chemistry, 52, (21), 2009, p6588-6598
Notes: [PubMed ID: 19821574]
DOI
More Publications and Other Research Outputs >>>
 

Log in to the TCD Portal

Contact:helpdesk@tcd.ie
Last Updated:28-JUL-2014